GlassScriptPhysician profile
George Black
NPI 1922427780
$34,887.87
in general payments reported to CMS, 2019-2025
31 companies · $5,530 in 2025
The $5,530 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,037 · 2020: $55.51 · 2021: $10K · 2022: $7,808 · 2023: $4,059 · 2024: $5,001 · 2025: $5,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,397 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,692.96 |
| Travel and Lodging | $2,397.22 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,560.03 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $4,678.63 | 2019-2025 | Gallant, Aveir, Ensite |
| Boston Scientific Corporation | $3,686.85 | 2019-2025 | Watchman Flx, Farapulse, General - Brady |
| Biotronik INC. | $2,913.13 | 2022-2024 | Acticor 7 Vr-T Dx |
| Altathera Pharmaceuticals LLC | $1,630.84 | 2025 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $1,596.96 | 2022-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Medical Device Business Services, INC. | $984.39 | 2023 | Carto 3 |
| Atricure, INC. | $356.64 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Philips North America LLC | $306.85 | 2022-2025 | (Am5) Lead Management, Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.69 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $153.46 | 2023-2025 | |
| Cardiva Medical, INC. | $125.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $115.69 | 2024-2025 | Eliquis, Camzyos |
| Zoll Respicardia, INC. | $88.32 | 2024 | Remede System |
| Cvrx, INC. | $56.28 | 2023 | Barostim Neo System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.17 | 2022-2023 | Jardiance |
| Teleflex LLC | $37.36 | 2025 | Turnpike |
| Terumo Medical Corporation | $31.69 | 2025 | Angio-Seal, Metacross Otw |
| Merck Sharp & Dohme LLC | $31.18 | 2023 | Verquvo |
| Daiichi Sankyo INC. | $24.45 | 2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $22.09 | 2024 | Onpattro |
| Pfizer INC. | $18.81 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $18.79 | 2023 | Arcalyst |
| Ethicon US, LLC | $18.19 | 2023 | Ethicon, Vistaseal, Stratafix |
| Convatec INC. | $17.94 | 2025 | |
| Chiesi USA, INC. | $17.58 | 2025 | Kengreal |
| Abiomed | $17.18 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $17.10 | 2024 | Arcalyst |
| Cordis US Corp. | $17.10 | 2025 | Mynx Control Venous |
| Sanofi-Aventis U.S. LLC | $16.41 | 2023 | |
| Amgen INC. | $15.88 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.